Delivery Order SPE2DB22D3016-SPE2DB25FBGA2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,588.31 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This is a firm fixed-price delivery order with a completion date of September 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,980.16 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment (UDGM) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,329.43 delivery order to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% eye ointment. The contract, which is not set-aside and carries a firm fixed price structure, was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025. Performance will be executed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $5,213.92 to AmerisourceBergen Drug Corp for Erythromycin 0.5% Eye Ointment on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,945.13 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This firm fixed price contract, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a straightforward pharmaceutical procurement executed through AmerisourceBergen's existing contract vehicle with DLA. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,368.29 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This firm fixed-price delivery order, awarded on June 3, 2025, with completion targeted for June 4, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation, and performance...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Erythromycin 0.5% eye ointment in 3.5-gram units. This firm fixed-price delivery order, valued at $2,076.50, represents a competitive award with no set-aside designation and is scheduled for completion by August 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This firm fixed-price delivery order, valued at $1,888.66, represents a competitive award with no set-aside designation and carries an ultimate completion date of September 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,110.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Erythromycin 0.5% eye ointment on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Erythromycin 0.5% Eye Ointment in 3.5-gram units, with a ceiling value of $2,247.57. This competitively awarded, firm fixed-price delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract contains no set-aside...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBGA2Delivery Order
The Defense Logistics Agency awarded a $4,755.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% eye ointment, with performance at the contractor's Conshohocken, Pennsylvania facility and an ultimate completion date of August 26, 2025. This non-competitive, non-set-aside delivery order was issued on August 25, 2025, and represents a discrete pharmaceutical supply requirement under the federal medical procurement framework supporting military and defense healthcare operations. This delivery order operates as a child contract under AmerisourceBergen's substantial $999.999 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. The prime IDV enables AmerisourceBergen to supply a broad range of pharmaceutical products, generic and brand-name medications, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The firm fixed-price structure and small commodity value reflect typical transactional patterns under this strategic pharmaceutical prime vendor agreement, which positions AmerisourceBergen as a critical supplier within the DLA's medical supply chain serving defense healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 8/25/25 |